Logo des HTGF

Portfolio Jobs

Browse through our portfolio jobs and select a suitable opportunity.

Our HTGF Portfolio of startups offers excellent opportunities and is always hiring talented people.

0
COMPANIES
0
JOBS

Global Development Lead - Executive Medical Director (MD Required)

Tubulis Technologies

Tubulis Technologies

Munich, Germany · Germany · Bavaria, Germany
Posted on Feb 13, 2026
Be part of our team

The Global Development Lead (GDL) – Executive Medical Director is accountable for the end-to-end clinical development strategy and execution of one or more antibody–drug conjugate (ADC) programs in gynecologic malignancies and other solid tumors. The GDL Leads cross-functional teams to ensure alignment and integration between Pharmacovigilance, Translational, Regulatory, Medical Affairs, and Commercial functions.

This role requires expertise in oncology drug development, a strong understanding of ADC-specific development challenges, and demonstrated scientific, medical, and clinical research expertise in gynecologic oncology.

The Global Development Lead – Executive Medical Director reports to the Vice President of Clinical Development and has direct management responsibility for Medical Directors leading gynecologic oncology clinical programs.

You will be part of a highly collaborative and cross-functional team involved with site evaluation, study start-up, study execution and management, and study close-out of our trials. This position will report to the VP, Clinical and Translational Development. The ideal candidate will be based in the Boston, MA region with remote opportunities available for candidates located in MA, NY, PA, RI, NJ, FL, or NC
Your mission

Program Strategy & Leadership

  • Accountable for designing and implementing the Clinical Development (CD) strategy and plans in gynecologic oncology from first-in-human through registration.
  • Lead and chair the Global Program Team (GPT), aligning Clinical Development, Translational Medicine, Regulatory Affairs, CMC, Safety, Biostatistics, Clinical Operations, Medical Affairs, and Commercial.
  • Define clear program objectives, milestones, and decision criteria, balancing speed, differentiation, and risk.
  • Ensure strategic coherence across indications, lines of therapy, combinations, and geographic regions.

Drug Development Leadership

  • Provides deep clinical expertise and scientific input into trials and portfolio decisions
  • Integrate ADC-specific considerations into program strategy, including:
    • Target biology and expression heterogeneity
    • Payload mechanism, linker stability, and bystander effects
    • Dose optimization and therapeutic index
    • Safety and tolerability based on emerging data
  • Collaborate cross functionally to ensure alignment between clinical strategy and CMC readiness, particularly for scale-up, comparability, and registrational supply.

Clinical & Regulatory Development

  • Work closely with Clinical Development leadership to ensure efficient execution of clinical studies, including meeting milestones.
  • Collaborates to develop the global regulatory strategy, including FDA, EMA, and other health authority interactions (e.g., EOP meetings, scientific advice, accelerated approval pathways).
  • define indication sequencing, trial design, endpoints, and comparator strategies in ovarian, endometrial, and cervical cancers.
  • Lead biomarker-driven development strategies, including patient selection, enrichment approaches, and companion/complimentary diagnostic considerations.
  • Oversees and participates in preparation of key program deliverables, including TPPs, integrated development plans, regulatory briefing documents, and governance materials.

Governance & Decision Making

  • Serve as the primary program representative to internal governance committees and executive leadership.
  • Lead scenario planning, risk assessments, and data-driven go/no-go decisions, particularly at PoC and registrational transition points.
  • Ensure timely escalation of issues with clear mitigation and contingency plans.

Cross-Functional Execution

  • Collaborate with program management to ensure integrated timelines, budgets, and resource planning across all functions.
  • Ensure alignment of clinical, translational, regulatory, and CMC critical paths, especially for registrational studies.
  • Mentors and coaches team members to foster a high-performing culture.

External Engagement

  • Support interactions with external partners, CROs, academic investigators, and key opinion leaders in gynecologic oncology.
  • Represent the program in selected external forums, including advisory boards and major oncology congresses (e.g., ASCO, ESMO, SGO).
Your profile
Qualifications:

Program Strategy & Leadership

  • Accountable for designing and implementing the Clinical Development (CD) strategy and plans in gynecologic oncology from first-in-human through registration.
  • Lead and chair the Global Program Team (GPT), aligning Clinical Development, Translational Medicine, Regulatory Affairs, CMC, Safety, Biostatistics, Clinical Operations, Medical Affairs, and Commercial.
  • Define clear program objectives, milestones, and decision criteria, balancing speed, differentiation, and risk.
  • Ensure strategic coherence across indications, lines of therapy, combinations, and geographic regions.

Drug Development Leadership

  • Provides deep clinical expertise and scientific input into trials and portfolio decisions
  • Integrate ADC-specific considerations into program strategy, including:
    • Target biology and expression heterogeneity
    • Payload mechanism, linker stability, and bystander effects
    • Dose optimization and therapeutic index
    • Safety and tolerability based on emerging data
  • Collaborate cross functionally to ensure alignment between clinical strategy and CMC readiness, particularly for scale-up, comparability, and registrational supply.

Clinical & Regulatory Development

  • Work closely with Clinical Development leadership to ensure efficient execution of clinical studies, including meeting milestones.
  • Collaborates to develop the global regulatory strategy, including FDA, EMA, and other health authority interactions (e.g., EOP meetings, scientific advice, accelerated approval pathways).
  • Define indication sequencing, trial design, endpoints, and comparator strategies in gynecological cancers and other solid tumors.
  • Lead biomarker-driven development strategies, including patient selection, enrichment approaches, and companion/complimentary diagnostic considerations.
  • Oversees and participates in preparation of key program deliverables, including TPPs, integrated development plans, regulatory briefing documents, and governance materials.

Governance & Decision Making

  • Serve as the primary program representative to internal governance committees and executive leadership.
  • Lead scenario planning, risk assessments, and data-driven go/no-go decisions, particularly at PoC and registrational transition points.
  • Ensure timely escalation of issues with clear mitigation and contingency plans.

Cross-Functional Execution

  • Collaborate with program management to ensure integrated timelines, budgets, and resource planning across all functions.
  • Ensure alignment of clinical, translational, regulatory, and CMC critical paths, especially for registrational studies.
  • Mentors and coaches team members to foster a high-performing culture.

External Engagement

  • Support interactions with external partners, CROs, academic investigators, and key opinion leaders in gynecologic oncology.
  • Represent the program in selected external forums, including advisory boards and major oncology congresses (e.g., ASCO, ESMO, SGO).

Qualifications

Education/Training

  • MD or MD/Ph.D with specialty training in gynecology and subspecialty training in gynecologic oncology is required.

Experience

  • 5+ years of pharmaceutical or biotechnology drug development experience with a focus on oncology drug development.
  • Demonstrated leadership of global, cross-functional development programs.
  • Direct experience in gynecologic malignancies strongly preferred.
  • Proven track record advancing programs through key clinical and regulatory milestones, including PoC and registrational trials.
  • Strong understanding of global regulatory expectations for oncology products, including expedited pathways.

Skills & Competencies

  • Well versed in Good Clinical Practice (GCP) and committed to upholding the highest standards of research integrity.
  • Proven matrix leadership with influence across functions and geographies.
  • Strategic thinker with strong execution rigor and attention to detail.
  • Ability to synthesize complex scientific, clinical, and operational data into clear recommendations for senior leadership.
  • Excellent communication and stakeholder-management skills.
Why us?
At Tubulis, curiosity and innovation drive us to transform cancer treatment. We are a fast-growing biotech where science meets passion—and where you have the chance to grow with us.

  • Impact that matters: Contribute to breakthrough therapies.
  • Global mindset: Work in an international, diverse team.
  • Grow & thrive: Develop your career in a supportive, fast-moving environment.
  • Innovation every day: Push boundaries with cutting-edge science.
At Tubulis, your ideas matter, your growth matters—and together, we make a difference.
About us
Tubulis is a clinical stage biotech company that generates uniquely matched antibody-drug conjugates (ADCs) with superior biophysical properties that have demonstrated durable on-tumor delivery and long-lasting anti-tumor activity in preclinical models. We recently closed on a Series C fundraising round totaling €344M (US $401M).

The development of novel, effective and safe therapies for the treatment of cancer is one of the main challenges for modern medicine. We want to drive this process forward. The main goal of Tubulis is to become a leading company in the field of targeted therapeutics and ADCs. With a strong team, our own technologies and innovative therapeutic concepts, we are ushering in a new era in the ongoing fight against cancer and share the vision of helping patients world-wide. Be part of a multidisciplinary and focused team, that works towards getting novel promising ADCs to patients with solid and hematological cancers.